Cyriel I J Ponsioen

Suggest Changes
Learn More
BACKGROUND Loss of response to anti-tumour necrosis factor (TNF) therapy in patients with inflammatory bowel disease (IBD) is often caused by anti-drug antibody formation with neutralisation of drug(More)